News
Buy 5 Medical Instruments Stocks to Enhance Your Portfolio
23 May 24
Earnings, News, Health Care, Small Cap, Markets, Analyst Ratings, Trading Ideas, General
Why RxSight (RXST) Shares Are Falling
9 May 24
News
Reported Earlier, RxSight Prices Public Offering Of 1,785,714 Common Stock At $56/Share
9 May 24
News
RxSight Announces $100M Proposed Public Offering Of Common Stock
8 May 24
News, Offerings
Wells Fargo Maintains Overweight on RxSight, Raises Price Target to $68
7 May 24
News, Price Target, Analyst Ratings
What 10 Analyst Ratings Have To Say About RxSight
7 May 24
Analyst Ratings
Oppenheimer Maintains Outperform on RxSight, Raises Price Target to $72
7 May 24
News, Price Target, Analyst Ratings
Needham Maintains Buy on RxSight, Raises Price Target to $75
7 May 24
News, Price Target, Analyst Ratings
BTIG Maintains Buy on RxSight, Raises Price Target to $72
7 May 24
News, Price Target, Analyst Ratings
RxSight Q1 2024 Adj EPS $(0.12) Beats $(0.27) Estimate, Sales $29.512M Beat $27.559M Estimate
6 May 24
Earnings, Earnings Beats, News
12 Health Care Stocks Moving In Monday's After-Market Session
6 May 24
Movers
Stifel Maintains Buy on RxSight, Raises Price Target to $68
6 May 24
News, Price Target, Analyst Ratings
Assessing RxSight: Insights From 8 Financial Analysts
11 Apr 24
Analyst Ratings
Needham Reiterates Buy on RxSight, Maintains $64 Price Target
11 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Press releases
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
5 Jun 24
News, Press Releases
Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board
30 May 24
News, Management, Press Releases
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
13 May 24
News, Financing, Press Releases
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
8 May 24
Press Releases
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
22 Apr 24
News, Press Releases
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
4 Apr 24
News, Press Releases, General